In Silico Quantitative Structure-Activity Relationship Studies on P-gp Modulators of Tetrahydroisoquinoline-Ethyl-Phenylamine Series by Gadhe, Changdev G et al.
RESEARCH ARTICLE Open Access
In Silico Quantitative Structure-Activity
Relationship Studies on P-gp Modulators of
Tetrahydroisoquinoline-Ethyl-Phenylamine Series
Changdev G Gadhe
1, Thirumurthy Madhavan
1, Gugan Kothandan
1, Seung Joo Cho
1,2*
Abstract
Background: Multidrug resistance (MDR) is a major obstacle in cancer chemotherapy. The drug efflux by a
transport protein is the main reason for MDR. In humans, MDR mainly occurs when the ATP-binding cassette (ABC)
family of proteins is overexpressed simultaneously. P-glycoprotein (P-gp) is most commonly associated with human
MDR; it utilizes energy from adenosine triphosphate (ATP) to transport a number of substrates out of cells against
concentration gradients. By the active transport of substrates against concentration gradients, intracellular
concentrations of substrates are decreased. This leads to the cause of failure in cancer chemotherapy.
Results: Herein, we report Topomer CoMFA (Comparative Molecular Field Analysis) and HQSAR (Hologram
Quantitative Structure Activity Relationship) models for third generation MDR modulators. The Topomer CoMFA
model showed good correlation between the actual and predicted values for training set molecules. The
developed model showed cross validated correlation coefficient (q
2) = 0.536 and non-cross validated correlation
coefficient (r
2) = 0.975 with eight components. The best HQSAR model (q
2 = 0.777, r
2 = 0.956) with 5-8 atom
counts was used to predict the activity of test set compounds. Both models were validated using test set
compounds, and gave a good predictive values of 0.604 and 0.730.
Conclusions: The contour map near R1 indicates that substitution of a bulkier and polar group to the ortho
position of the benzene ring enhances the inhibitory effect. This explains why compounds with a nitro group have
good inhibitory potency. Molecular fragment analyses shed light on some essential structural and topological
features of third generation MDR modulators. Fragments analysis showed that the presence of tertiary nitrogen, a
central phenyl ring and an aromatic dimethoxy group contributed to the inhibitory effect. Based on contour map
information and fragment information, five new molecules with variable R1 substituents were designed. The
activity of these designed molecules was predicted by the Topomer CoMFA and HQSAR models. The novel
compounds showed higher potency than existing compounds.
Background
MDR, the principal mechanism by which many cancers
develop resistance to chemotherapy drugs, is a major
factor in the failure of many forms of chemotherapy [1].
In MDR tumour cells, various member of the ABC
family of transport proteins can simultaneously be over-
expressed: these include P-gp (ABCB1), breast cancer
resistance protein (BCRP, ABCG2) and MDR associated
protein 1 (MRP1, ABCC family) [2]. These transporters
utilize energy from ATP hydrolysis to transport a wide
variety of substances out of cells against concentration
gradients. The active efflux of substances from cells
decreases their intracellular concentration and results in
failure of chemotherapy.
Among the 49 identified human ABC transporters,
P-gp is most intensively studied [3], and is a member
of MDR/TAP (transporter associated proteins) subfam-
ily. P-gp has ability to transport a wide variety of
structurally unrelated substances out of cells [4-6]. P-
gp is extensively distributed and expressed in the
intestinal epithelium, hepatocytes, renal proximal tubu-
lar cells, adrenal gland and capillary endothelial cells
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gp transports structurally diverse substrates and most
are anticancer drugs such as doxorubicin, daunorubi-
cin, paclitaxel, etoposid, teniposid, vinblastine and vin-
cristine [7]. P-gp does not interact with anionic
compounds but does interact with amphipathic com-
pounds with molecular masses between 400-1900 dal-
tons [8,9]. The calcium channel blocker verapamil can
overcome MDR in cancer cells [10]. Another drug,
cyclosporine-A, was designed as an immunosuppres-
sant, but shows a promising P-gp inhibitory effect.
Both these drugs are used as first generation P-gp inhi-
bitors, also called MDR modulators. The use of these
modulators has been limited because of low efficacy
and higher dose-related toxicity. The second genera-
tion modulators, dexverapamil and PSC833, had higher
efficacy and lower toxicity, but produce serious drug-
drug interactions clinically.
Nowadays, a third-generation of MDR modulators are
under investigation. These drugs, which include tariqui-
dar (XR9576), zosuquidar (LY335979) and laniquidar
(R1010933), possess selectivity, low toxicity and high
efficacy [11]. These modulators are structurally different
from the first- and second-generation modulators. Early
in their evaluation, these modulators displayed promis-
ing activity. However, toxicity was subsequently
observed [12]. The toxicities were found not to be
mechanism based. These modulators showed some
potential as new drugs, but were dropped due to toxi-
city related to high dose to be effective physiologically.
Therefore, there is a clear need to enhance the activity
of modulators that would also reduce the required
dose. The search for new nontoxic, efficacious, potent
modulators without drug-drug interactions has been
intensive. The studies include a 3D-QSAR and free
Wilson analysis on a series of tariquidar analogues as
MDR modulators [13], a QSAR study on anthranila-
mide derivatives containing the nucleus of XR9576 and
a 3D-QSAR study using tariquidar derivatives (WK-X
and WK-Y compounds) to develop QSAR CoMFA/
CoMSIA models [14]. With the aim to find out impor-
tant groups and atoms for P-gp antagonism, the pre-
sent study selected a third-generation MDR modulator
to develop Topomer CoMFA and HQSAR models [15].
This series consisted of same tetrahydroisoquinoline-
ethyl-phenyl-amine nucleus present in two of the
aforementioned series.
Methods
Data Set
The activity dataset, which was selected from reported
literature [15], consisted of 39 molecules (Table 1). For
analysis, the given inhibitory concentration values were
changed to minus logarithmic scale value (pIC50), as a
dependent variable for Topomer CoMFA and HQSAR
analysis by using the formula provided below. It is
common to convert the biological activity data into a
logarithmic scale, because the resulting model behaves
Table 1 Structures and biological activities of the dataset
compounds
Compound R1 R2 X pIC50
4 OCH3 Phenyl - 5.39
5a* OCH3 2-Nitrophenyl - 5.27
5b H 2-Nitrophenyl - 4.85
6a OCH3 2-Aminophenyl - 5.07
6b* H 2-Aminophenyl - 5.00
7a OCH3 4-Nitrophenyl - 5.85
7b H 4-Nitrophenyl - 5.25
8a OCH3 4-Aminophenyl - 5.32
8b H 4-Aminophenyl - 4.92
9 OCH3 3-Quinolinyl - 6.24
9b H 3-Quinolinyl - 6.37
10* OCH3 2-Quinolinyl - 6.07
11 OCH3 4-Quinolinyl - 5.33
12 OCH3 6-Quinolinyl - 6.17
13 OCH3 2-Quinoxalinyl - 6.33
14 OCH3 1-Naphthyl - 5.85
15* OCH3 2-Naphthyl - 6.20
16 OCH3 3-Pyridyl - 5.32
17 OCH3 2-Bromophenyl - 5.48
18 OCH3 3-Bromophenyl - 5.74
19 OCH3 4-Bromophenyl - 5.62
20 OCH3 3,4-Dimethoxyphenyl - 5.38
21 OCH3 4,5-Dimethoxy-2-nitrophenyl - 4.89
22 OCH3 3,4-Methylendioxyphenyl - 5.68
23* OCH3 Phenyl -CH=CH- 5.85
24* OCH3 2-Nitrophenyl -CH=CH- 5.96
25 OCH3 4-Chlorophenyl -CH=CH- 6.17
26 OCH3 4,5-Dimethoxy-2-nitrophenyl -CH=CH- 5.82
27 OCH3 Phenyl -CH2-O- 5.51
28 OCH3 2-Nitrophenyl -CH2-O- 6.66
29* OCH3 2-Aminophenyl -CH2-O- 5.47
30a OCH3 2-Nitrophenyl -NH- 6.48
30b H 2-Nitrophenyl -NH- 6.11
31 OCH3 3-Nitrophenyl -NH- 6.17
32 OCH3 4-Nitrophenyl -NH- 5.82
33a OCH3 2-Aminophenyl -NH- 4.68
33b* H 2-Aminophenyl -NH- 4.72
34 OCH3 3-Aminophenyl -NH- 4.85
35 OCH3 4-Aminophenyl -NH- 4.52
Asterisk (*) indicates test set compounds.
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models.
pIC log (IC ) 55 00 =−
The dataset was randomly partitioned into training
and test set molecules by considering range of molecules
(pIC50 = 4.52-6.66), so that both the training and test
sets consist of high, medium and low activity molecules.
The training and test set consist of 31 and 8 molecules,
respectively. All the molecules were built using the
SYBYL 8.1 molecular modeling package [16]. All the
dataset molecules were sketched by the SYBYL sketch-
ing program and were minimized by using the Tripos
f o r c ef i e l d .T h e yw e r et h e ns u b j e c t e dt os i m u l a t e d
annealing to get a stable conformation. Simulated
annealing was performed for each ligand up to 200
cycles with default parameters, and then conformations
were sorted according to the least potential energy
value. These conformations were minimized with quan-
tum mechanical semi-empirical AM1 method with pre-
cise convergence and full optimization commands with
MMOK (Molecular Mechanics Correction to CONH
Bonds) keywords. The dataset was then used for Topo-
mer CoMFA and HQSAR analysis.
Topomer CoMFA
A Topomer CoMFA technique merges CoMFA [17] and
topomer technology, to overcome the alignment pro-
blem of CoMFA [18]. Topomer CoMFA includes align-
ment of structural fragments. Structural fragments by
definition contain a common feature, the “open valence”
or “attachment bond”. The Topomer methodology over-
laps this common feature to provide an absolute orien-
tation for any fragment. A Topomer is an invariant
three-dimensional (3D) representation of molecular sub-
unit generated from its two-dimensional (2D) topology
by topomer alignment in topomer CoMFA [19]. In
Topomer CoMFA analysis, all molecules of dataset were
divided into two fragments, shown as R1 (blue) and R2
(red) groups in Figure 1. Each Topomer fragment was
applied with topomer alignment to make a 3D invariant
representation [20]. In Topomer CoMFA, atomic
charges were calculated by the Gasteiger-Marsilli
method for the topomer structure. Topomer CoMFA
acts in two different ways for the calculation of molecu-
lar fields. An ‘attenuation factor’ reduces the field con-
tributions of fragment atoms more distant from the
attachment bond. Finally, the r
2 is calculated by using
the same optimum number of component obtained
from leave-one-out (LOO) cross validation analysis.
Topomer CoMFA steric and electrostatic fields were
calculated at a regular space grid of 2 Å, and were fixed
automatically into a 1000 point cube to contain a Topo-
mer. A sp
3 hybridized carbon atom was used as a probe
atom for the steric field calculation and a negative oxy-
gen atom was used as a probe for electrostatics field.
Partial Least Square (PLS)
The relationship between structural parameters and bio-
logical activities of compounds under study has been
quantified using a PLS algorithm [21-23]. Topomer
CoMFA descriptors were used as independent variable
and biological activity (pIC50) as a dependent variable.
The cross-validation analysis was performed by using
the LOO method, in which one molecule is removed
from the dataset and its activity is predicted by using
the model derived from rest of the molecules in the
dataset. The q
2 resulted in an optimum number of com-
ponents and the lowest standard error of prediction.
The q
2 is calculated using the following equation:
q
pred actual
actual mean
2
2
2 1 =−
−
−
∑
∑
()
()




where gpred, gactual and gmean are predicted, actual and
mean values of the target property (pIC50), respectively.
Predictive Correlation Coefficient (r
2
pred)
The predictive power of Topomer CoMFA and HQSAR
models were derived from set of eight molecules, which
were excluded during model development. In the struc-
tural preparation of test set molecules, sketching and
optimization was same as the training set molecules.
The activity of the test set was predicted by using model
derived from training set. The predictive correlation
coefficient for developed model was determined by
using following formula:
r
SD PRESS
SD
pred
2 =
− ()
where, PRESS is the sum of the squared deviation
between the predicted and actual activity of the test set
Figure 1 Fragmentation pattern (R1 and R2) for all molecules
of dataset in topomer CoMFA analysis. R1 fragment is
represented by the blue color and R2 fragment is denoted by the
red color.
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deviation between the biological activity of the test set
compounds and the mean activity of the training set
molecules.
HQSAR
HQSAR is a technique that employs fragment finger-
prints as predictive variables of biological activity or
other structural related data [24]. HQSAR does not
require a 3D structure of bioactive conformation or
molecular alignments. HQSAR model generation deals
with the 2D structure directed fragment fingerprints
[25]. These molecular fingerprints are broken into
strings at fixed intervals as specified by a hologram
length (HL) parameter. The HL determines the number
of bins in the hologram into which the fragments are
hashed. The optimal HQSAR model was derived from
screening through the 12 default HL values, which were
a set of 12 prime numbers ranging from 53-401. The
model development was performed using the following
parameters: atom (A), bond (B), connection (C), chirality
(Ch), hydrogen (H) and donor/acceptor (DA). The valid-
ity of the model depends on statistical parameters such
as r
2, q
2 by LOO, predictive r
2
pred and standard error.
The robustness of the model depends on the more chal-
lenging test set prediction reflected by its predictive
r
2
pred value.
Results and Discussion
Topomer CoMFA Model Analysis
The Topomer CoMFA model with good predictive abil-
ity in terms of r
2 (goodness of fit of the model) and q
2
(internal predictivity of the model) was presently devel-
oped. The model displayed a q
2 =0 . 5 3 6a n dr
2 = 0.975,
with 0.460 standard error of prediction and 0.110 stan-
dard error of estimate. The number of components that
provided the highest q
2 was eight. The summary of PLS
results is provided in Table 2. The predictive ability of
the developed topomer CoMFA model was assessed by
the test set (eight molecules) predictions, which were
excluded during the Topomer CoMFA model genera-
tion. The predictive ability of the test set was 0.604. The
actual and predicted activities of the training set and
test set molecules, along with the R1 and R2 fragment
contributions are given in Table 3. The graph of
predicted versus actual activity for training set and test
set molecule is shown in Figure 2.
Contour Map Analysis
Topologically aligned R1 and R2 fragments are shown in
Figure 3. Topomer CoMFA steric and electrostatic
Table 2 Statistical results of Topomer CoMFA including
various parameters
N q
2 StdErr r
2 SEE F r
2
pred
8 0.536 0.460 0.975 0.110 105.9 0.604
N = Number of components, q
2-LOO cross-validated correlation coefficient,
r
2-Non-cross-validated correlation coefficient, StdErr-Standard error of
prediction, SEE-Standard error of estimate, F-Fischer test value, r
2
pred-Predicted
correlation coefficient.
Table 3 Actual and predicted activities of the training set
and the test set molecules with R1 and R2 fragment
contributions
Fragment
Contributions
Compound Actual pIC50 Predicted pIC50 R1 R2
4 5.39 5.23 0.39 0.40
5b 4.85 4.84 0.38 0.02
6a 5.07 4.86 0.02 0.40
7a 5.85 5.49 0.65 0.40
7b 5.25 5.11 0.65 0.02
8a 5.36 5.17 0.34 0.40
8b 4.92 4.79 0.34 0.02
9 6.24 6.27 1.44 0.40
9b 6.37 5.89 1.44 0.02
11 5.33 5.24 0.40 0.40
12 6.19 5.98 1.15 0.40
13 6.33 6.16 1.32 0.40
14 5.85 5.65 0.81 0.40
16 5.32 5.10 0.26 0.40
17 5.48 5.19 0.36 0.40
18 5.74 5.60 0.76 0.40
19 5.62 5.40 0.56 0.40
20 5.38 5.19 0.36 0.40
21 4.89 4.72 -0.12 0.40
22 5.68 5.40 0.56 0.40
25 6.17 5.97 1.14 0.40
26 5.82 5.67 0.83 0.40
27 5.51 5.50 0.66 0.40
28(temp) 6.66 6.64 1.80 0.40
30a 6.48 6.44 1.60 0.40
30b 6.11 6.06 1.60 0.02
31 6.17 6.24 1.41 0.40
32 5.82 5.78 0.94 0.40
33a 4.68 4.73 -0.11 0.40
34 4.85 4.74 -0.10 0.40
35 4.52 4.44 -0.40 0.40
Test set
5a 5.27 5.22 0.38 0.40
6b 5.00 4.48 0.02 0.02
10 6.07 6.24 1.40 0.40
15 6.20 6.16 1.32 0.40
23 5.85 5.74 0.90 0.40
24 5.96 6.44 1.60 0.40
29 5.47 5.81 0.97 0.40
33b 4.72 4.35 -0.11 0.02
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Page 4 of 15contour maps for the R1 and R2 fragments of the most
active molecule (28) are shown in Figure 4. Contour
level along with color scheme and estimated volume of
contour are summarized in Table 4. In the steric con-
tour map, the green color denotes sterically bulky
groups favoured for activity and the yellow color indi-
cates sterically bulky groups unfavoured for activity. In
the electrostatics contour map, red indicates electrone-
gative-favoured groups and blue indicates electroposi-
tive-favoured group. The steric contour map for the R1
fragment (Figure 4A) indicated that the bulky 2-nitro
group on the phenoxy ring was favourable for activity.
The electrostatics contour map (Figure 4B) indicated
that the 2-position was favourable for polar electronega-
tive substituent and, hence, compound 28 displayed the
highest activity (pIC50 = 6.66) among all the com-
pounds. In compound 29 (pIC50 = 5.47), the 2-nitro
group of compound 28 was replaced by the 2-amino
group, which produced less of an inhibitory effect. The
electropositive nature of the amino group was not
favourable for activity when located at the 2-position on
phenyl ring, and showed decreased inhibitory potency.
For compound 27 (pIC50 = 5.51), the unsubstituted phe-
nyl ring was not favoured for activity; the compound
displayed less inhibitory potency than compound 28.
For the R2 fragment, the dimethoxy substitution was
important for the inhibitory effect (Figures 4C and 4D).
The green contour near the methyl group indicated that
the bulky group was favoured for the inhibitory effect
and the red color near the oxygen atom indicated that
an electronegative substitution could retain molecular
activity. The data supports the idea that the methyl
group allows a hydrophobic interaction with a receptor,
with an oxygen atom acting as a hydrogen-bond accep-
tor. This indicates the hydrophilic interaction with
receptor, which echoes earlier observations [14].
Steric and electrostatic contour maps for compound
30a (pIC50 = 6.48) are shown in Figure 5. Fragment R1
consisted of a urea substituted derivative. The steric
contour (Figure 5A) revealed that a phenyl ring with a
2-nitro substitution is favoured for activity. The electro-
static contour map (Figure 5B) indicated that the elec-
tron withdrawing nature of the nitro group was
favourable for increasing inhibitory potency. For com-
pound 30b (pIC50 = 6.11), removal of the dimethoxy
group from the R2 fragment produced a decreased
activity compared to compound 30a, indicating the
necessity of the dimethoxy substitution for the inhibi-
tory effect. For compound 31 (pIC50 = 6.11), and 32
(pIC50 = 5.82), the position of nitro group played a
major role in the inhibitory effect, as a para-substituted
phenyl ring (compound 32) displayed less inhibitory
potency than a meta-substituted phenyl ring (compound
31). The yellow contour corresponding to the para posi-
tion of the phenyl ring indicated that a bulky group at
this position was unfavourable for activity, perhaps due
to the steric restriction of the receptor pocket. For com-
pound 33a (pIC50 =4 . 6 8 ) ,3 4( p I C 50 = 4.85) and 35
(pIC50 = 4.51), amino group substitutions at the ortho,
meta and para positions led to the least-active com-
pounds, indicating that, for P-gp inhibitory effect, a
polar electronegative group (nitro) was more favourable
than an electropositive group (amino).
Steric and electrostatic contour maps for compound
13 (pIC50 = 6.33) are shown in Figure 6. Fragment R1
consisted of an amide-substituted derivative. The steric
contour map (Figure 6A) revealed that the bulky nature
of the quinoxalinyl ring was favourable for inhibitory
potency. The electrostatics contour map (Figure 6B)
revealed that the electropositive nature of quinoxalinyl
ring was favoured for increased inhibitory potency.
Replacement of the quinoxalinyl ring by a 2-naphthyl
Figure 2 Scatter plot diagram for Topomer CoMFA analysis.
Predicted versus actual activity of the training set (blue diamond)
and the test set (red square) compounds.
Figure 3 Topological alignment of R1 and R2 fragments
generated by Topomer CoMFA analysis.
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the inhibitory potency. Compound 13 was more electro-
positive than compound 15, because the two lone pairs
of nitrogen atoms in the quinoxalinyl ring increased the
electropositivity of the ring, boosting the inhibitory
potency of compound 13, relative to compound 15.
Removal of a dimethoxy group from the R2 fragment
decreased the inhibitory potency. For compound
8b (pIC50 = 4.92), removal of the dimethoxy groups
produced the least potent compound.
Steric and electrostatic contour maps for compound
5b (pIC50 = 4.85) are presented in Figure 7. The steric
c o n t o u rm a pf o rf r a g m e n tR 1( F i g u r e7 A ) ,w h i c hd i s -
played a yellow contour near the 2-nitro position, was
Figure 4 Steric and electrostatics stdev* coefficient contour map for compound 28 by Topomer CoMFA analysis. (A) Steric contour map
for the R1 fragment. (B) Electrostatic contour map for the R1 fragment. (C) Steric contour map for the R2 fragment. (D) Electrostatics contour
map for the R2 fragment. Sterically favoured/unfavoured areas are shown in green/yellow contour, while the blue/red polyhedra depict the
favourable sites for the positively/negatively charged groups.
Table 4 Topomer CoMFA contour map for the R1 and R2 fragments
Contour R1 R2
Contour level Color Volume estimate Contour level Color Volume estimate
Steric -0.014 Yellow 14.9 0.000 Yellow 0.00
0.037 Green 29.6 0.008 Green 9.70
Electrostatics -0.014 Blue 19.5 0.000 Blue 0.00
0.032 Red 9.60 -0.004 Red 19.8
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position for the inhibitory effect. The electrostatic con-
tour map for the R1 fragment (Figure 7B), which dis-
played a red contour near the nitro groups, indicated
that the position was favorable for an electronegative
group. For compound 17 (pIC50 = 5.48), compound 18
(pIC50 = 5.78) and compound 19 (pIC50 =5 . 6 2 ) ,s u b s t i -
tutions with the less bulky and electronegative bromine
at ortho, meta and para positions improved the potency
over compound 5b. Fragment R2 (Figures 7C and 7D)
displayed green and red contours near positions 6 and 7
of the 3,4-dihydroisoquinoline ring, indicating the
importance of the dimethoxy group for the inhibitory
effect. In contrast, the presence of a dimethoxy group in
compound 5a (pIC50 = 5.27) improved potency over
compound 5b.
HQSAR analysis
The HQSAR model with good predictive ability in terms
of r
2 and q
2 was presently developed. The model shows
q
2 = 0.777 and r
2 = 0.956 with 0.302 standard error of
prediction and 0.105 standard error of estimate. The
model was developed with bond (B), connection (C) and
donor acceptor (DA) parameters with BHL = 97. The
number of components that provided the highest q
2 was
six. Table 5 summarizes the PLS results. The predictive
ability of the developed HQSAR model was assessed by
the test set (eight molecules) predictions, which were
Figure 5 Steric and electrostatics stdev* coefficient contour map for compound 30a by Topomer CoMFA analysis. (A) Steric contour
map for the R1 fragment. (B) Electrostatic contour map for the R1 fragment. (C) Steric contour map for the R2 fragment. (D) Electrostatics
contour map for the R2 fragment. Sterically favoured/unfavoured areas are shown in green/yellow contour, while the blue/red polyhedra depict
the favourable site for the positively/negatively charged groups.
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tive ability of the test set was 0.730. The actual and pre-
dicted activities of the training set and test set
molecules are given in Table 6. The graph of predicted
versus actual activities for the training set and test set
molecules is shown in Figure 8.
Numerous models with combinations of the A/B/C/H/
Ch/DA parameters with 4-7 atom counts are given in
Table 7. Parameters such as B/C/DA were important for
model generation. Bond and connection considered the
bond order and hybridization states within fragments,
respectively, and DA yielded information about the
donor and acceptor atoms. The highest q
2 value was
obtained for parameters B/C/DA; for further improve-
ment of q
2, an optional atom count (1-10) was explored.
A significant difference was noticed in the statistical
parameters with different atom counts for model B/C/
DA (Table 8).
A standard color coding system was used to indicate
atomic contributions in the HQSAR model. Red, red-
orange and orange designated unfavourable and negative
contribution to the activity, while yellow, green-blue and
green denoted favourable or positive contribution to the
activity. White indicated an intermediate contribution to
activity. For study of atomic contribution, molecules
were selected randomly. The positive and negative
atomic contributions for the selected molecules are
s h o w ni nA d d i t i o n a lf i l e1 .A l lt h em o l e c u l e si nt h e
dataset had a common substructure and varied only in
R1 and R2 substructure. The contribution map for
Figure 6 Steric and electrostatics stdev* coefficient contour map for compound 13 by Topomer CoMFA analysis. (A) Steric contour map
for the R1 fragment. (B) Electrostatic contour map for the R1 fragment. (C) Steric contour map for the R2 fragment. (D) Electrostatics contour
map for the R2 fragments. Sterically favoured/unfavoured areas are shown in green/yellow contour, while the blue/red polyhedra depict the
favourable site for the positively/negatively charged groups.
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positively to activity (pIC50 = 6.17), whereas the remain-
der displayed an intermediate contribution to activity.
The contribution map for compound 13 (pIC50 =6 . 3 3 )
indicated that the quinoxalin-2-carboxamide substituent
contributed positively to the inhibitory effect. This result
was consistent with the Topomer CoMFA results. The
contribution map for compound 19 (pIC50 = 5.62) indi-
cated that the R2 side chain contributed in an inter-
mediate fashion to activity. But, the central phenyl ring
contributed positively to activity. For compound 26
(pIC50 = 5.82), the contribution map revealed that [(4,
5-dimethoxy-2-nitrophenyl)-acrylamide] substituents
contributed positively to activity, while the remainder
of the structure contributed in an intermediate fashion
to the inhibitory effect. The highly active compound 28
of the series (pIC50 = 6.66) contributed in a positive and
intermediate manner to activity. The R2 side chain
(2-nitrophenoxy-acetamide) substitution contributed in
Figure 7 Steric and electrostatics stdev* coefficient contour map for compound 5b by Topomer CoMFA analysis. (A) Steric contour map
for the R1 fragment. (B) Electrostatic contour map for the R1 fragment. (C) Steric contour map for the R2 fragment. (D) Electrostatics contour
map for the R2 fragment. Sterically favoured/unfavoured areas are shown in green/yellow contour, while the blue/red polyhedra depict the
favourable site for the positively/negatively charged groups.
Table 5 Statistical results of HQSAR including various
parameters
Nq
2 StdErr r
2 SEE r
2
pred BHL
HQSAR 6 0.777 0.302 0.973 0.105 0.730 97
N = Number of components, q
2-LOO cross-validated correlation coefficient,
r
2-Non-cross-validated correlation coefficient, StdErr-Standard error of
prediction, SEE-Standard error of estimate, r
2
pred-Predicted correlation
coefficient, BHL-best hologram length.
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Page 9 of 15an intermediate manner. The central phenyl ring and
isoquinoline ring displayed a positive contribution to
activity. Similarly, another highly active compound in
the series, 30a (pIC50 = 6.48), displayed similar results.
The R2 side chain consisting of 2-nitrophenylurea sub-
stituents contributed moderately to activity, and the
central phenyl and isoquinoline rings contributed fairly
positive to activity. Compound 7b (pIC50 = 5.25) showed
a moderate contribution to activity and compound 9b
(pIC50 = 6.37) contributed moderately and positively to
the inhibitory effect.
HQSAR mainly deals with the fragments; the final
HQSAR model with B/C/DA parameters generated
thousands of fragments. Correlation of each fragment
with biological activity was impossible. Instead, the frag-
ments produced by HQSAR were analyzed. This analysis
shed light on some of the important features; some
representative molecular fragments are displayed in Fig-
ure 9. The fragment analysis indicated that fragments
possessing positive values contributed favourably to
activity, while fragments possessing negative values con-
tributed unfavourably to activity. Fragment F1, which
had a positive coefficient value of 0.010, possessed ter-
tiary nitrogen connected to the aromatic ring with ethyl
Table 6 Actual and predicted activities for the training
set and the test set by HQSAR model
Compound Actual pIC50 Predicted pIC50
4 5.39 5.23
5b 4.85 4.84
6a 5.07 4.86
7a 5.85 5.49
7b 5.25 5.11
8a 5.36 5.17
8b 4.92 4.79
9 6.24 6.27
9b 6.37 5.89
11 5.33 5.39
12 6.19 6.21
13 6.33 6.34
14 5.85 5.77
16 5.32 5.37
17 5.48 5.51
18 5.74 5.57
19 5.62 5.63
20 5.38 5.38
21 4.89 4.92
22 5.68 5.63
25 6.17 6.10
26 5.82 5.92
27 5.51 5.42
28(temp) 6.66 6.62
30a 6.48 6.52
30b 6.11 6.14
31 6.17 6.07
32 5.82 5.96
33a 4.68 4.53
34 4.85 4.78
35 4.52 4.58
Test set
5a 5.27 5.27
6b 5.00 4.99
10 6.07 5.98
15 6.20 6.06
23 5.85 5.25
24 5.96 6.21
29 5.47 5.53
33b 4.72 4.31
Figure 8 Scatter plot diagram for HQSAR analysis. The scatter
plot displays the predicted versus actual activities of the training set
(blue diamond) and the test set (red square) of compounds.
Table 7 Different statistical parameter obtained for
HQSAR models
Model Fragment distinction N q
2 StdErr r
2 SEE BHL
1 A/B 6 0.432 0.482 0.908 0.194 353
2 A/DA 6 0.504 0.45 0.935 0.162 199
3 B/DA 6 0.671 0.367 0.951 0.142 97
4 A/B/C 6 0.658 0.374 0.945 0.149 151
5 A/B/Ch 6 0.661 0.372 0.945 0.150 151
6 A/B/DA 6 0.731 0.332 0.961 0.125 353
7 B/C/DA 6 0.772 0.305 0.956 0.134 97
8 A/B/C/Ch 6 0.661 0.372 0.945 0.150 151
9 A/B/H/DA 6 0.713 0.342 0.958 0.130 257
10 A/B/Ch/DA 6 0.733 0.33 0.963 0.122 353
10 A/B/C/H/Ch 6 0.375 0.505 0.910 0.192 307
11 A/B/C/Ch/DA 6 0.705 0.347 0.966 0.118 151
12 A/B/C/H/DA 6 0.676 0.364 0.959 0.130 307
13 A/B/H/DA/Ch 6 0.704 0.348 0.957 0.132 257
14 A/B/C/H/DA/Ch 5 0.603 0.395 0.894 0.204 151
A-atom; B-bond; C-connection; Ch-chirality; DA-donor/acceptor; Best model is
highlighted in bold font.
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Page 10 of 15linker. This fragment was present in all molecules of the
data set, indicating the importance of tertiary nitrogen
for the inhibitory effect. This fragment may be preferred
when designing a new scaffold for P-gp antagonism.
Fragment F2, which contained an ethyl phenyl ring with
a coefficient value of 0.001, was also present in all mole-
cules of the dataset. Fragment F3, which had the same
coefficient value, was present in some molecules. Frag-
ment F3 contained a methoxy group on the aromatic
ring; the fragment plays an important role in a favour-
able hydrophobic interaction, consistent with previous
results [14]. The oxygen residue of the methoxy group
acts as a hydrogen bond acceptor, which supports
hydrophilic interaction with receptor, also consistent
with previous observations [14]. In this particular series
of compounds, the tetrahydroisoquinoline moiety
was either unsubstituted or was substituted by a 6,
7-dimethoxy group. The difference in inhibitory effect of
the dimethoxy substituted and unsubstituted com-
pounds suggest that this substructure might be impor-
tant in the inhibitory effect. Fragment F4 displayed a
positive contribution of 0.004 for activity and was pre-
sent in all molecules as a central phenyl ring. It might
act through hydrophobic interactions with receptors, as
has been previously suggested [13]. Fragment F6 was
present in molecule 11 (pIC50 =5 . 3 3 )a n dc o n t r i b u t e d
Table 8 Statistical parameters obtained for model 7 with
different atom counts
Atom Count N q
2 StdErr r
2 SEE BHL
1-4 6 0.511 0.447 0.871 0.230 151
2-5 6 0.636 0.385 0.900 0.202 307
3-6 5 0.683 0.352 0.950 0.141 353
4-7 6 0.772 0.305 0.956 0.134 97
5-8 6 0.777 0.302 0.973 0.105 97
6-9 4 0.726 0.321 0.948 0.140 353
7-10 6 0.770 0.306 0.979 0.092 307
The final model chosen for HQSAR analysis is highlighted in bold font.
Figure 9 Positive and negative contribution of some fragments towards P-gp antagonism, obtained by HQSAR analysis. Grey = carbon
atoms, where C2, C3 and Car indicates sp
2,s p
3 and aromatic carbon. Red = oxygen atom, where O2 and O3 indicates sp
2 and sp
3 oxygen,
respectively. Blue = nitrogen atom, where N3, Nar indicates sp
3 and aromatic nitrogen. Blue = ANY atom, and it may be hydrogen, carbon or
oxygen.
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Page 11 of 15negatively for activity, with a coefficient of -0.002. This
result indicates that the 4-quinoline substituent contri-
butes negatively to activity and decreases inhibitory
potency. Fragment F7 consisted of a 3-quinoline nucleus
and was present in compound 9 (pIC50 =6 . 2 4 )a n d9 b
(pIC50 = 6.37); the fragment contributed positively to
activity (coefficient of 0.008). The aromatic (3-quinolinyl)
‘N’ acts as a hydrogen-bond acceptor with the appropriate
amino acid of the receptor [14]. Fragment F8 was present
in molecules 27 (pIC50 = 5.51), 28 (pIC50 = 6.66) and 29
(pIC50 = 5.47), where it contributed positively to the inhi-
bitory effect (coefficient of 0.006); these results indicate
that an ether linker is more important for an inhibitory
effect. Fragment F9 was present in the urea derivative
compound; its’ contribution coefficient of 0.004 was indi-
cative of an inhibitory effect, highlighting the importance
of urea substituted derivatives for the inhibitory effect.
The model generated by both Topomer CoMFA and
HQSAR agreed well with each other. The HQSAR ana-
lysis showed that tertiary nitrogen with an ethyl phenyl
linker was essential for activity and that a dimethoxy
group was necessary in inhibition of P-gp. Urea and
ether linker were most important for the inhibitory
effect and contributed profoundly. The fragment from
the isoquinoline ring was also vital for activity and for
the inhibitory effect.
Klinkhammer paper is about structure activity rela-
tionship (SAR) and this manuscript describes quantita-
tively structure activity relationship (QSAR), which is
consistent with the previous paper. The present
approach is in-depth study, i.e., contour map analyses of
CoMFA and fragment analyses of HQSAR provided
guidelines concerning compound modification.
The presently-developed QSAR models yielded similar
findings as XR9576 reports [26]. The third-generation
MDR modulators have the same scaffold as XR9576,
with different side chains. The sterically bulky side chain
of XR9576 could be responsible for the higher inhibitory
effect [26]. This view is supported by the present find-
ings of favourable steric (green) and electrostatic (blue)
contour maps around the R1 fragment. It also highlights
the importance of fused benzo rings. In the current
model, the fused ring containing compounds (such as
quinolinyl, quinoxalinyl and naphthyl) are predicted to
show higher activity. The XR9576 report also high-
lighted the importance of the positional effect of nitro-
gen in quinolinyl ring for inhibitory potency [26]. This
positional effect was presently confirmed quantitatively.
Designing New Compounds
Ligand-based methods such as Topomer CoMFA are not
computationally intensive and can lead to the rapid gen-
eration of QSARs, from which the biological activity of
newly designed compounds can be predicted. In contrast,
an accurate prediction of activity of untested compounds
based on the computation of binding free energies is
both complicated and lengthy. The Topomer CoMFA
contour maps provide clear indicators for designing
novel molecules with improved P-gp inhibitory potency.
The careful analyses of contour maps and HQSAR results
led to the identification of the structural requirements
responsible for compounds having improved potency.
The information obtained from the contour maps of the
most potent molecule (28; Figure 4) was utilized to
design new R1 fragment containing compounds.
It was assumed that the 2-nitro group on the phenyl
ring is favourable and responsible for retaining higher
potency of inhibitors. The electrostatically favourable
blue color at the para position of the 2-nitrophenoxy
ring indicates that substituents with an electron-rich
group at this position might increase the activity. Pre-
sently, a chlorine group was substituted at the para posi-
tion and the phenoxy-acetamide group was replaced by
N’-keto-benzohydrazide group. The resulting compound
(28B) displayed improved inhibitory potency over com-
pound 28. Here, using information obtained from the
Table 9 Designed molecular fragments along with their
predicted activities by Topomer CoMFA and HQSAR
analysis
Molecule
number
R1 Fragments Predicted
Activity
Topomer
CoMFA
HQSAR
28A 6.66 6.62
28B 6.94 6.78
28C 6.74 6.79
28D 6.60 6.52
28E 6.57 6.34
For all designed molecules, the variable part is the R1 fragment.
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Page 12 of 15Topomer CoMFA model, five new R1 fragment contain-
ing compounds were designed, which displayed signifi-
cant increases in activity. These newly designed
compounds were included in the test set and their activ-
i t yw a sp r e d i c t e db yt h eT o p o m e rC o M F Aa n dH Q S A R
models (Table 9). The Topomer CoMFA contour map
was predicted for the designed compound 28B shown in
Figure 10. The (E)-N-3-(2-nitrophenyl)acrylamide (R1
fragment of compound 24) was replaced by a (2Z,4E)-5-
(2-nitrophenyl)penta-2,4-dienenitrile (28A fragment)
substituent, which resulted in equipotent compound as
28. The 2-nitrophenyl group remained unchanged
because of its delicacy and importance at particular
position for inhibitory effect, which corresponded to the
sterically and electrostatically favourable contour maps.
Another highly potent compound 28 derivative (28C)
was designed by replacing the 2-nitrophenoxy-acetamide
group of compound 28 by 2-(5-(4-chlorocyclohexyl)-1-
methyl-1H-imidazol-2ylthio)-N-acetamide. Here, the
essential 2-nitrophenyl group was replaced by methyl
substituted imidazole group by considering its positional
and steric effects. The sterically favourable bulky nature
of the nitro group was replaced by a methyl group,
which corresponded to the favourable green contour
map. The fifth position of the imidazole ring was substi-
tuted with a 4-chlorocyclohexyl group. The electron-
rich chloro group at this position was favourable for
improved inhibitory potency, which corresponded to the
blue contour map in the vicinity.
To check the importance of ortho substituents on the
inhibitory effect, the nitro group was removed from the
ortho position of compound 28. Decreased inhibitory
potency was observed in compound 28D, indicating that
retention of inhibitory potency of an inhibitor requires
Figure 10 Steric and electrostatics stdev* coefficient contour map for designed compound 28B by Topomer CoMFA analysis. (A) Steric
contour map for the R1 fragment. (B) Electrostatic contour map for the R1 fragment. (C) Steric contour map for the R2 fragment. (D)
Electrostatics contour map for the R2 fragment. Sterically favoured/unfavoured areas are shown in green/yellow contour, while the blue/red
polyhedra depict the favourable site for the positively/negatively charged groups.
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Page 13 of 15substitution of the phenyl ring with an ortho nitro
group. Steric and electrostatic contour maps for the R2
fragment of 28B are displayed in Figure 10, and demon-
strate the importance of a sterically bulky methoxy
group for the inhibitory effect. We analyzed individual
atomic contribution map of newly designed molecules
for inhibitory effect. It indicates that the R1 fragment of
designed molecules contribute positively towards the
inhibitory effect, as denoted by the blue, green-blue and
yellow color in HQSAR.
In summary, utilizing information obtained from the
Topomer CoMFA and HQSAR analyses, we designed
novel fragment containing compounds, which had higher
inhibitory potency than the reported compound. From
the overall analyses, we conclude that the 2-nitrophenyl
group, which has a steric as well as polar nature, is
responsible for the higher affinity of the molecules. Addi-
tionally, designed fragments underscore the importance
of electron-rich substituents at the para position of the
phenyl and cyclohexyl ring system.
Conclusion
We derived Topomer CoMFA and HQSAR models with
good statistical values. The robustness of these models
was confirmed using a test set. Topomer CoMFA analy-
sis provided great insight into the structural require-
ments for improved potency over existing compounds.
The information obtained from HQSAR model shows
the importance of bond, connection and donor/acceptor
parameters. The overall study indicates that, in HQSAR
analysis, fragments containing information about the
dimethoxy group are important for an inhibitory effect;
this was supported by the findings of the Topomer
CoMFA contour map. The contour map for ether and
urea linking fragments (R1) indicate that substitution of
bulkier and polar group to the ortho position of benzene
ring enhances the inhibitory effect, and explains why the
compounds with nitro group have good inhibitory
potency. Contour map analysis also revealed that bulky
and more electropositive substituents on the amide lin-
ker are responsible for higher potency; this was sup-
ported by the HQSAR atomic contribution map.
A central phenyl ring could hydrophobically interact
with a receptor and so is important in the inhibitory
effect. In summary, both HQSAR and Topomer CoMFA
underscore the importance of the aromatic dimethoxy
and nitro groups for the inhibitory effect. Molecular
modeling techniques like Topomer CoMFA and HQSAR
aid the identification of the functional groups and atoms
important for the inhibitory potency. Together, these
data can be utilized to design more potent compounds
than the present series of compounds.
Additional material
Additional file 1: Contribution map. Positive and negative contribution
map for few molecules obtained by HQSAR analysis.
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